ArticleBMC cancer2013

Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study.

Ágnes Márk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.